|
Market Closed -
OTC Markets
12:08:04 02/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0702 USD | -9.26% |
|
-5.10% | -56.69% |
| 19/08 | Avicanna Inc. announced that it has received CAD 0.5 million in funding | CI |
| 19/08 | Avicanna Closes C$500,000 Private Placement to Pharmaceutical Investor Michael Porter | MT |
Company Valuation: Avicanna Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 49.1 | 35.79 | 30.73 | 31.74 | 33.62 | 26.56 |
| Change | - | -27.12% | -14.14% | 3.27% | 5.92% | -20.99% |
| Enterprise Value (EV) 1 | 48.53 | 37.42 | 32.75 | 33.06 | 33.28 | 26.28 |
| Change | - | -22.88% | -12.49% | 0.97% | 0.65% | -21.03% |
| P/E | -1.17x | -1.92x | -1.65x | -3.39x | -8.43x | -9.36x |
| PBR | 7.81x | 31.2x | -80.1x | -282x | 14.5x | 9.34x |
| PEG | - | 0x | 0x | 0.1x | 0.1x | 0.3x |
| Capitalization / Revenue | 31.3x | 10.9x | 7.59x | 1.89x | 1.32x | 1.04x |
| EV / Revenue | 30.9x | 11.4x | 8.09x | 1.97x | 1.31x | 1.03x |
| EV / EBITDA | -2.77x | -3.45x | -3.34x | -4.2x | -8.04x | -11.7x |
| EV / EBIT | -2.66x | -3.28x | -3.15x | -3.95x | -7.11x | -9.44x |
| EV / FCF | -6.9x | -4x | -4.97x | -8.46x | -18.1x | -47.4x |
| FCF Yield | -14.5% | -25% | -20.1% | -11.8% | -5.51% | -2.11% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.118 | -0.4063 | -0.249 | -0.1032 | -0.0362 | -0.0241 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1.57 | 3.269 | 4.048 | 16.79 | 25.46 | 25.48 |
| EBITDA 1 | -17.49 | -10.85 | -9.812 | -7.871 | -4.138 | -2.243 |
| EBIT 1 | -18.27 | -11.41 | -10.41 | -8.38 | -4.68 | -2.782 |
| Net income 1 | -32.86 | -16.77 | -14.74 | -8.743 | -3.618 | -2.759 |
| Net Debt 1 | -0.5788 | 1.631 | 2.016 | 1.326 | -0.3388 | -0.2806 |
| Reference price 2 | 1.3100 | 0.7800 | 0.4100 | 0.3500 | 0.3050 | 0.2250 |
| Nbr of stocks (in thousands) | 37,485 | 45,884 | 74,953 | 90,677 | 1,10,215 | 1,18,042 |
| Announcement Date | 03/09/21 | 31/03/22 | 31/03/23 | 02/04/24 | 11/04/25 | 01/04/26 |
1CAD in Million2CAD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.73x | 7.77x | 15.61x | 1.37% | 7.45TCr | |
| 31.25x | 9.01x | 28.06x | 0.04% | 6.01TCr | |
| 33.64x | 6.03x | 18.07x | 0.97% | 4.82TCr | |
| 34.63x | 3.34x | 14.4x | -.--% | 4.43TCr | |
| -21.16x | 229.18x | -22.81x | -.--% | 4.4TCr | |
| 47.94x | 5.54x | 30.43x | -.--% | 4.16TCr | |
| 26.89x | 7.76x | 19.96x | 0.42% | 3TCr | |
| 33.91x | 7.26x | 18.84x | -.--% | 2.93TCr | |
| -70.02x | 13.44x | -68.51x | -.--% | 2.49TCr | |
| Average | 15.42x | 32.15x | 6.01x | 0.31% | 4.41TCr | |
| Weighted average by Cap. | 19.58x | 31.88x | 10.24x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AVCN Stock
- AVCNF Stock
- Valuation Avicanna Inc.
Select your edition
All financial news and data tailored to specific country editions
